US Stock MarketDetailed Quotes
BXPHF BOTANIX PHARMACEUTICALS LTD
- 0.271
- 0.0000.00%
15min DelayClose Sep 9 16:00 ET
491.60MMarket Cap-45166P/E (TTM)
0.000High0.000Low0Volume0.000Open0.271Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.81BShares0.50052wk High6.78P/B491.60MFloat Cap0.00952wk Low--Dividend TTM1.81BShs Float0.500Historical High--Div YieldTTM0.00%Amplitude0.009Historical Low--Avg Price1Lot Size
BOTANIX PHARMACEUTICALS LTD Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | ||||||
| Cash from discontinued investing activities | ||||||
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | -155.18%-18M | -141.41%-7.05M | -35,184.02%-2.92M | 94.52%-8.28K | -1,037.89%-151.19K | -13.29K |
| Net PPE purchase and sale | -1,388.38%-112.7K | -5.05%-7.57K | 12.96%-7.21K | 90.80%-8.28K | -577.74%-90.05K | ---13.29K |
| Net intangibles purchase and sale | -153.85%-17.89M | -141.75%-7.05M | ---2.91M | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---61.14K | ---- |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | -155.18%-18M | -141.41%-7.05M | -35,184.02%-2.92M | 94.52%-8.28K | -1,037.89%-151.19K | ---13.29K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 331.68%95.1M | 14,554.06%22.03M | -21.44%-152.41K | -100.34%-125.5K | 6,460.84%37.31M | 568.65K |
| Net issuance payments of debt | ---- | --1 | ---- | ---- | ---- | ---- |
| Net common stock issuance | 329.30%95.1M | --22.15M | ---- | ---- | 6,464.90%37.33M | --568.65K |
| Net other financing activities | ---- | 19.68%-122.41K | -21.44%-152.41K | -443.79%-125.5K | ---23.08K | ---- |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | 331.68%95.1M | 14,554.06%22.03M | -21.44%-152.41K | -100.34%-125.5K | 6,460.84%37.31M | --568.65K |
| Net cash flow | ||||||
| Beginning cash position | 40.69%10.25M | -66.20%7.29M | -12.54%21.55M | 423.87%24.65M | -72.75%4.7M | --17.26M |
| Current changes in cash | 2,276.86%68.97M | 120.35%2.9M | -359.68%-14.26M | -115.67%-3.1M | 257.31%19.8M | ---12.59M |
| Effect of exchange rate changes | 36.88%86.16K | 676.67%62.95K | -194.70%-10.92K | -91.91%11.53K | 439.59%142.52K | --26.41K |
| End cash Position | 673.71%79.31M | 40.69%10.25M | -66.20%7.29M | -12.54%21.55M | 423.87%24.65M | --4.7M |
| Free cash flow | -36.59%-26.13M | -35.60%-19.13M | -373.94%-14.11M | 82.94%-2.98M | -32.65%-17.45M | ---13.15M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data